article · ALEXMED ePosters
IntroductionIdiopathic intracranial hypertension (IIH) is a clinical disorder of unknown etiology that is defined by symptoms and signs of raised intracranial pressure (ICP) in absence of dilated ventricles, with normal cerebrospinal fluid (CSF) composition, and no other cause of raised ICP identified on neuroimaging or other evaluation.Patients with IIH usually present with manifestations related to increased ICP like headache, visual disturbances (like blurred vision or double vision), pulsatile tinnitus, nausea, vomiting, and neck or shoulder pain, often accompanied by papilledema. The target of IIH management is to reduce ICP with the main goals of preservation of vision and relief of headache. Managing idiopathic intracranial hypertension often includes a combination of lifestyle changes, such as weight loss, and medications like acetazolamide to lower intracranial pressure. Surgical intervention in indicated in patients with acute visual deterioration and those with severe headache despite adequate conservative measures. surgical intervention include optic nerve decompression surgery, venous sinus stenting or a CSF Diversion like lumboperitoneal shunt (LPS) or Ventriculoperitoneal (VPS).
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.21608/alexpo.2025.396646.2198
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.